Rothblatt Martine A exercised Options for 9,500 United Therapeutics shares and sold 9,500 shares on September 3, 2026. The disclosed exercise and sale price ranges, along with post-transaction holdings of 324,443 shares and 499,410 derivative securities, give investors the transaction’s ownership detail.

Key Highlights

  • Rothblatt Martine A held 499,410 United Therapeutics derivative securities after exercising options at $0 per share.
  • The share exercises covered two transactions, while the sales were completed through 12 transactions.
  • Post-sale direct ownership stood at 324,443 United Therapeutics shares.

Rothblatt Martine A exercised options for 9,500 United Therapeutics shares and sold 9,500 shares in transactions on September 3, 2026. The options were exercised at prices ranging from $117.76 to $135.42 per share, while the sales occurred between $479.07 and $491.25 per share.

United Therapeutics Transactions Span Shares and Options

The share exercises were completed in two transactions under transaction code M. Rothblatt Martine A’s 9,500-share sale was spread across 12 transactions under transaction code S. A separate set of option exercises covered 9,500 derivative securities across two transactions at $0 per share. Following those exercises, Rothblatt Martine A owned 499,410 United Therapeutics derivative securities.

Post-Transaction Ownership Balances

Rothblatt Martine A owned 333,943 United Therapeutics shares after the share exercises. The transaction record separately identifies direct shares and derivative securities, with the latter totaling 499,410 after the option exercises.